Big Gain For Theriva Biologics, Inc.
Mon, Apr 20, 2026 at 07:21 PM
Theriva Biologics, Inc. (TOVX:NYSEMKT) rocketted at $0.41, a gain of 59.4%. On Mon, Apr 20, 2026, TOVX:NYSEMKT touched a New 2-Week High of $0.41. The stock got featured on our News Catalysts scanner on Fri, Apr 17, 2026 at 05:33 PM in the 'BIOTECH' category. From Mon, Apr 06, 2026, the stock recorded 50.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Oct 24, 2025 at $0.85 with a volume of 549M+.
About Theriva Biologics, Inc. (TOVX:NYSEMKT)
Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics.
Top 10 Gainers:
- Enveric Biosciences, Inc. (ENVB:NASDAQ), 100.55%
- Hempacco Co., Inc. (HPCO:NASDAQ), 100%
- Theriva Biologics, Inc. (TOVX:NYSEMKT), 59.41%
- FGI Industries Ltd. (FGI:NASDAQ), 50.62%
- Psyence Biomedical Ltd. (PBM:NASDAQ), 48.68%
- Julong Holding Limited (JLHL:NASDAQ), 48.66%
- COMPASS Pathways plc (CMPS:NASDAQ), 42.04%
- CN Energy Group. Inc. (CNEY:NASDAQ), 41.59%
- Beyond Meat, Inc. (BYND:NASDAQ), 41.02%
- Cue Biopharma, Inc. (CUE:NASDAQ), 40.15%